Kirin Brewery

Kirin Brewery, a core subsidiary of Kirin Holdings, is a Japanese company that has successfully leveraged its foundational expertise in fermentation and microbiology to become a significant player in the life sciences and biotechnology sectors. While its primary consumer identity is linked to the beverage industry, the company's R&D in yeast and fermentation led to the establishment of its pharmaceutical business, which eventually merged with Kyowa Hakko to form Kyowa Kirin. Today, the Kirin Group operates across three domains: Food & Beverages, Pharmaceuticals, and Health Science, with a focus on immunology, oncology, and nephrology. Its Health Science division specifically targets the gut-brain axis and immune health through proprietary ingredients like Lactococcus lactis strain Plasma. The company is recognized for its advanced antibody engineering platforms, such as POTELLIGENT technology, which enhances the efficacy of therapeutic antibodies.